Furthermore, our results did not exhibit effect of either GSTO1 (rs4925) or GSTO2 (rs156697 and rs2297235) polymorphisms on overall survival among female ccRCC patients (Figure 1c). The gene discussed is GSTO2; the disease is nonpapillary renal cell carcinoma.